Himadri Speciality Chemical Limited (HSCL) Gross Profit 2022–2026

Name: Himadri Speciality Chemical Limited (HSCL) gross profit history 2022-2026
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-09-20

Himadri Speciality Chemical Limited annual gross profit for fiscal 2026 was ₹17.4 billion, an increase of 20.8% from ₹14.4 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

HSCL Annual Gross Profit

Gross Profit (annual)	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Gross Profit	₹17.4B	₹14.4B	₹11.5B	₹9.1B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

HSCL Quarterly Gross Profit

Gross Profit (quarterly)	2026-06-30	2026-03-31	2025-12-31	2025-06-30	2025-03-31	2024-12-31
Gross Profit	₹5.2B	₹5.0B	₹4.4B	₹4.1B	₹3.9B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Gross Profit at Comparable Companies

4401 Gross Profit — Adeka Corporation
5301 Gross Profit — Tokai Carbon Co., Ltd.
4202 Gross Profit — Daicel Corporation
4118 Gross Profit — Kaneka Corporation
7966 Gross Profit — LINTEC Corporation
4208 Gross Profit — UBE Corporation

More HSCL metrics: Revenue · Operating Income · Net Income · EPS · Free Cash Flow

All HSCL financial statements → Interactive HSCL charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.